Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DURECT Corporation

http://www.durect.com

Latest From DURECT Corporation

CES Roundup: Holoportation, Empathic Robot, Aging Suit, Bionic Prosthetic Arm, Headband For Better Sleep

In this second roundup from CES, Medtech Insight shines the light on Proto Hologram’s many use cases in health care, Intuition Robotics’ ElliQ robot to help the elderly feel less lonely, MIT AgeLab’s Aging Suit, Siemens/Unlimited Tomorrow’s partnership on a bionic prosthetic arm, and Earable Neuroscience’s Frenz Brainband to promote better sleep.

Digital Health Artificial Intelligence

Durect Eyes Phase III In Alcoholic Hepatitis Despite Phase IIb Miss

Durect thinks its epigenetic modulator shows promise with data showing reduction in 90-day mortality despite missing the primary endpoint of mortality and liver transplant rate.

Clinical Trials Business Strategies

Adcock Remains Resilient In Tough Business Environment

Adcock saw its profits grow by 4.2% during FY 2024 despite a challenging economic environment.

Sales & Earnings South Africa

‘Clinically Meaningful Outcomes’ Data Urged For Long-Acting, Local Anesthetic Drug Products

Although a new FDA guidance recommends difference in pain scores as the primary efficacy endpoint for evaluation of postoperative analgesic effect, data on outcomes such as reduction in hospitalization and deaths from opioid abuse would be valuable and could provide a basis for inclusion in labeling; guidance is part of broader agency effort to reduce opioid use.

Drug Approval Standards Guidance Documents
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
UsernamePublicRestriction

Register